相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Progressive Development of Cefiderocol Resistance in Escherichia coli During Therapy is Associated With an Increase in blaNDM-5 Copy Number and Gene Expression
Patricia J. Simner et al.
CLINICAL INFECTIOUS DISEASES (2022)
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies
Jean-Francois Timsit et al.
CLINICAL INFECTIOUS DISEASES (2022)
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
Marco Falcone et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
The urgent need for metallo-β-lactamase inhibitors: an unattended global threat
Maria F. Mojica et al.
LANCET INFECTIOUS DISEASES (2022)
Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2021)
Cefiderocol as Rescue Therapy for Acinetobacter baumannii and Other Carbapenem-resistant Gram-negative Infections in Intensive Care Unit Patients
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2021)
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study
Marco Falcone et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens
Jacob E Choby et al.
LANCET INFECTIOUS DISEASES (2021)
Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia
Takayuki Katsube et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study
Renato Pascale et al.
JAC-ANTIMICROBIAL RESISTANCE (2021)
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study
Renato Pascale et al.
JAC-ANTIMICROBIAL RESISTANCE (2021)
Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019
Lara Tavoschi et al.
EUROSURVEILLANCE (2020)
Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase-Producing Enterobacterales During a Regional Outbreak
Marco Falcone et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria
Shazad Mushtaq et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
In vitro activity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe
Christopher Longshaw et al.
JAC-ANTIMICROBIAL RESISTANCE (2020)
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2016)